National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

190

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C03DA01	ALDACTONE	B	Spironolactone - 25mg	25mg	Tablet	237,860 L.L
D07XC04	TRAVOCORT	B	Diflucortolone valerate - 0.1%, Isoconazole nitrate - 1%		Cream	435,405 L.L
L01EA04	BOSULIF	B	Bosutinib - 100mg	100mg	Tablet, film coated	35,663,747 L.L
L02BB03	CASODEX	B	Bicalutamide - 150mg	150mg	Tablet, film coated	10,863,782 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 400mg	400mg	Injectable lyophilised powder for solution+diluent	450,187 L.L
N05AX13	BYANNLI	B	Paliperidone - 700mg	700mg	Injectable suspension, prolonged release	96,913,176 L.L
V01AA	STALORAL	B	Allergen extracts - 2 x 100IR ou IC/ml		Solution	8,449,319 L.L
L01EA04	BOSULIF	B	Bosutinib - 400mg	400mg	Tablet, film coated	123,564,667 L.L
L02BB04	XTANDI	B	Enzalutamide - 40mg	40mg	Capsule, soft	278,248,572 L.L
N03AG01	DEPAKINE CHRONO	B	Valproic acid - 145mg, Sodium Valproate - 333mg	500mg	Tablet, coated, scored, prolonged release	362,837 L.L
V01AA	STALORAL	B	Allergen extracts - 300 IR ou IC/ml		Solution	6,598,267 L.L
A10BX02	NOVONORM	B	Repaglinide - 1mg	1mg	Tablet	571,133 L.L
L01EA04	BOSULIF	B	Bosutinib - 500mg	500mg	Tablet, film coated	154,453,246 L.L
R05DB13	SINECOD	B	Butamirate dihydrogenocitrate - 5mg/ml	5mg/ml	Drops	287,582 L.L
V01AA	STALORAL	B	Allergen extracts - 10-100-100 IR ou IC/ml	10-100-100 IR ou IC/ml	Solution	9,129,688 L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Suppository	4,153,817 L.L
J01MA02	CIPROBAY	B	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film coated	654,451 L.L
L01EA05	ICLUSIG	B	Ponatinib - 15mg	15mg	Tablet, film coated	103,555,839 L.L
L02BB05	ERLEADA	B	Apalutamide - 60mg	60mg	Tablet, film coated	264,151,186 L.L
V01AA	STALORAL	B	Allergen extracts - 10-300 IR ou IC/ml	10-300 IR ou IC/ml	Solution	7,206,963 L.L
A07EC02	SALOFALK	B	Mesalazine - 1g	1g	Suppository	3,948,209 L.L
A10BX16	MOUNJARO KWIKPEN	B	Tirzepatide - 2.5mg/dose	2.5mg/dose	Injectable solution	39,601,065 L.L
L01EA05	ICLUSIG	B	Ponatinib - 45mg	45mg	Tablet, film coated	207,092,651 L.L
L02BB06	NUBEQA	B	Darolutamide - 300mg		Tablet, film coated	239,808,442 L.L
V01AA	DIATER	B	Allergen extracts -		Spray	26,856,672 L.L
A07EC02	SALOFALK	B	Mesalazine - 4g/60ml	4g/60ml	Enema	3,796,355 L.L
A10BX16	MOUNJARO KWIKPEN	B	Tirzepatide - 5mg/dose	5mg/dose	Injectable solution	39,601,065 L.L
C09CA04	APROVEL	B	Irbesartan - 150mg	150mg	Tablet, film coated	651,764 L.L
L01EB01	IRESSA	B	Gefitinib - 250mg	250mg	Tablet, fim coated	135,027,509 L.L
L02BG03	ARIMIDEX	B	Anastrozole - 1mg	1mg	Tablet, film coated	3,202,377 L.L

...

190